-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Ganaplacide + Lumefantrine) in Malaria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Ganaplacide + Lumefantrine) in Malaria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Ganaplacide + Lumefantrine) in Malaria Drug Details: A fixed-dose combination...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ivaltinostat in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ivaltinostat in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ivaltinostat in Pancreatic Ductal Adenocarcinoma Drug Details: Ivaltinostat is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Luxeptinib in Relapsed Acute Myeloid Leukemia
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Luxeptinib in Relapsed Acute Myeloid Leukemia Drug Details: CG-806 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Luxeptinib in Refractory Acute Myeloid Leukemia
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Luxeptinib in Refractory Acute Myeloid Leukemia Drug Details: CG-806 is under development for the...
-
Sector Analysis
Italy Agtech Market Summary, Competitive Analysis and Forecast to 2027
Agtech in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - AgTech refers to the use of technology in farming and agriculture aimed to improve the efficiency, productivity, and sustainability of food production. The global AgTech market is rapidly growing as a result of population growth,...
-
Company Profile
U.S. Stem Cell Inc – Company Profile
U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell-based therapeutics products. The company’s lead product MyoCell is an autologous muscle stem cell therapy for improving cardiac functions of a patient with serious, chronic heart damage due to heart attack. Its other lead product is MyoCell SDF-1, an improvement of MyoCell for similar applications; AdipoCell, a proprietary kit used for the isolation of adipose (fat) derived...
Add to Basket -
Product Insights
Vascular Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Vascular Grafts Pipeline Products Market Report Overview Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. These are the implants used to repair, bypass, or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta. The vascular grafts pipeline market research report provides comprehensive information...
-
Product Insights
Net Present Value Model: Luxeptinib
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Luxeptinib Drug Details CG-806 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – INXN-4001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry INXN-4001 Drug Details INXN-4001 is under development for the treatment of heart failure. The...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PTX-9908
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PTX-9908 Drug Details PTX-9908 is under development for the treatment of liver cancer and...